Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series

@inproceedings{Fornaro2011SwitchingFS,
  title={Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series},
  author={Michele Fornaro},
  booktitle={Annals of general psychiatry},
  year={2011}
}
BACKGROUND Serotonin reuptake inhibitors (SRIs) currently represent the cornerstone of obsessive-compulsive disorder (OCD) pharmacotherapy. However, OCD is characterized by high rates of partial and/or absent response to standard, recommended treatments, often prompting pharmacological and non-pharmacological augmentation or switching of strategies. Agomelatine, a novel melatonin agonist and selective serotonin antagonist (MASSA) antidepressant approved for major depressive disorder (MDD) has… CONTINUE READING
14 Citations
43 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Structured Clinical Interview for DSM-IV axis I (SCID-I), clinician version Washington, DC: American Psychiatric Association

  • MB First, M Gibbon, RL Spitzer, JBW Williams
  • 1997
Highly Influential
4 Excerpts

The assessment of anxiety states by rating

  • M Hamilton
  • Br J Med Psychol
  • 1959
Highly Influential
9 Excerpts

Similar Papers

Loading similar papers…